CAI
Clinical Asset Index
by VOS Supply Group
Drugs · acquisition-cost intelligence

clobetasol propionate

· ingredient clobetasolCorticosteroids, plain· CLOBETASOL PROPIONATE .5 mg/mL
What this is. Acquisition-cost intelligence for pharmacy & clinic buyers — the historical trend, generic-equivalent costs, and Part D posture. NADAC is a pharmacy acquisition cost (the national average pharmacies pay), not a retail or cash price — for consumer cash prices use GoodRx/your plan.
Acquisition benchmark · NADAC per ML
$0.11487
NADAC — pharmacy acquisition cost, not a retail/cash price

Acquisition-cost history

Weekly NADAC per ML — the trend nobody else shows. 6 weeks.

2025-12-172026-05-20

Same-ingredient options by acquisition cost

Other clobetasol products, cheapest acquisition cost first. Per ML — confirm strength/form equivalence before switching.

ProductNADAC / MLvs this
Clobetasol Propionate$0.12147+$0.00660
Clobetasol Propionate Cream 0.05% Clobetasol Propionate Cream 0.05%$0.15938+$0.04450
clobetasol propionate$0.17794+$0.06310
Clobex$0.24543+$0.13060
clobetasol propionate$0.32513+$0.21030
CLOBEX$0.33318+$0.21830
Clobex$0.34854+$0.23370
Clobetasol Propionate (emollient)$0.58990+$0.47500

Medicare Part D coverage · CY2026

On 310 plan formularies · typical tier 4
Prior auth 0% · Step therapy 0% · Quantity limit 65% of formularies

Sources: CMS NADAC (pharmacy acquisition cost), FDA NDC + RxNorm (identity), RxClass (therapeutic class), CMS Medicare Part D formulary (coverage). Observed reference data for professional buyers — not a retail/cash price, not pricing or medical advice. Verify before purchasing or substituting.